Literature DB >> 21925769

Mitochondrial DNA deletions cause the biochemical defect observed in Alzheimer's disease.

Kim J Krishnan1, Thiloka E Ratnaike, Heidi L M De Gruyter, Evelyn Jaros, Doug M Turnbull.   

Abstract

Alzheimer's disease (AD) is the most common form of dementia, increasing in prevalence with age. Most patients who develop AD have an unknown cause, but characteristic neuropathological features include the deposition of extracellular amyloid beta and of intraneuronal hyperphosphorylated tau protein. Researchers have previously implicated mitochondrial dysfunction in AD. We previously showed an increase in neurons displaying a mitochondrial biochemical defect-cytochrome-c oxidase (COX) deficiency-in the hippocampus in patients with sporadic AD compared with age-matched controls. COX deficiency is well described as a marker of mitochondrial (mt) DNA dysfunction. This present study analyzed the mtDNA in single neurons from both COX normal and COX-deficient cells. Analysis of the mtDNA revealed that COX deficiency is caused by high levels of mtDNA deletions which accumulate with age. Future research is needed to clarify the role mtDNA deletions have in normal aging and investigate the relationship between mtDNA deletions and the pathogenesis of sporadic AD.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21925769     DOI: 10.1016/j.neurobiolaging.2011.08.009

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  40 in total

Review 1.  Mitochondrial dysfunction in Alzheimer's disease: Role in pathogenesis and novel therapeutic opportunities.

Authors:  Judit M Perez Ortiz; Russell H Swerdlow
Journal:  Br J Pharmacol       Date:  2019-03-06       Impact factor: 8.739

Review 2.  Genome instability in Alzheimer disease.

Authors:  Yujun Hou; Hyundong Song; Deborah L Croteau; Mansour Akbari; Vilhelm A Bohr
Journal:  Mech Ageing Dev       Date:  2016-04-20       Impact factor: 5.432

3.  Mitochondrial Complex I Deficiency in Schizophrenia and Bipolar Disorder and Medication Influence.

Authors:  Brandi L Rollins; Ling Morgan; Brooke E Hjelm; Adolfo Sequeira; Alan F Schatzberg; Jack D Barchas; Francis S Lee; Rick M Myers; Stanley J Watson; Huda Akil; Steven G Potkin; William E Bunney; Marquis P Vawter
Journal:  Mol Neuropsychiatry       Date:  2017-11-30

4.  Base excision DNA repair levels in mitochondrial lysates of Alzheimer's disease.

Authors:  Chandrika Canugovi; Raghavendra A Shamanna; Deborah L Croteau; Vilhelm A Bohr
Journal:  Neurobiol Aging       Date:  2014-01-08       Impact factor: 4.673

Review 5.  Mitochondrial genome changes and neurodegenerative diseases.

Authors:  Milena Pinto; Carlos T Moraes
Journal:  Biochim Biophys Acta       Date:  2013-11-16

Review 6.  Mitochondrial DNA deletions in Alzheimer's brains: a review.

Authors:  Nicole R Phillips; James W Simpkins; Rhonda K Roby
Journal:  Alzheimers Dement       Date:  2013-07-11       Impact factor: 21.566

Review 7.  New Therapeutics to Modulate Mitochondrial Function in Neurodegenerative Disorders.

Authors:  Heather M Wilkins; Jill K Morris
Journal:  Curr Pharm Des       Date:  2017       Impact factor: 3.116

Review 8.  Mitochondria, Cybrids, Aging, and Alzheimer's Disease.

Authors:  R H Swerdlow; S Koppel; I Weidling; C Hayley; Y Ji; H M Wilkins
Journal:  Prog Mol Biol Transl Sci       Date:  2017-02-01       Impact factor: 3.622

9.  The Effects of APOE4 on Mitochondrial Dynamics and Proteins in vivo.

Authors:  Shira Simonovitch; Eran Schmukler; Eliezer Masliah; Ronit Pinkas-Kramarski; Daniel M Michaelson
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

10.  Mitochondrial DNA damage in a mouse model of Alzheimer's disease decreases amyloid beta plaque formation.

Authors:  Milena Pinto; Alicia M Pickrell; Hirokazu Fukui; Carlos T Moraes
Journal:  Neurobiol Aging       Date:  2013-05-21       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.